Product Program year 2025 Source: CMS Open Payments

Optis

Device Vascular

PDI 05415067037558

Open in the dashboard

General payments

$2,263,350

10,843 payments

Research payments

$13,635

11 payments

Through program year 2025, $2,263,350 in general payments and $13,635 in research payments were reported against Optis (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 Research $9,685 8
2024 General $909,195 3,427
2023 General $1,099,849 4,824
2023 Research $3,700 2
2022 General $254,306 2,592
2021 Research $250 1

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $2,263,350 10,843 payments
Top recipients General payments · program year 2024
  1. Jason Wollmuth Interventional Cardiology · Portland, OR $52,978 6% · 51 payments
  2. Kevin Croce Cardiovascular Disease · Chestnut Hill, MA $52,837 6% · 53 payments
  3. Brian Bergmark Cardiovascular Disease · Boston, MA $45,731 5% · 31 payments
  4. Duane Pinto Interventional Cardiology · Boston, MA $35,010 4% · 45 payments
  5. Kathleen Kearney Interventional Cardiology · Seattle, WA $31,060 3% · 36 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $438,193 51% · 358 practitioners
  2. Cardiovascular Disease Internal Medicine $277,764 32% · 185 practitioners
  3. Diagnostic Radiology Radiology $36,288 4% · 11 practitioners
  4. Internal Medicine $34,144 4% · 47 practitioners
  5. Vascular Surgery Surgery $29,878 3% · 4 practitioners

The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Massachusetts $139,885 15% · 17 recipients
  2. New York $108,533 12% · 121 recipients
  3. Florida $73,764 8% · 42 recipients
  4. California $72,007 8% · 53 recipients
  5. Oregon $58,835 6% · 6 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

10,843 general · 11 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record